Mark Stevens is the co-founder of Travera and serves as the Interim CEO. Mark also holds the titles of VP of Clinical Development and Director of Clinical Development within the company. Mark has a background in research and project management, previously working as a Technical Project Lead at Dana-Farber Cancer Institute and a Ph.D. Candidate at MIT. With a focus on developing mass-based biomarkers for cancer therapy guidance, Mark has demonstrated expertise in interdisciplinary research and collaboration within the scientific community.
This person is not in the org chart
This person is not in any teams
This person is not in any offices